The purpose of this study is to evaluate the performance of the apparent diffusion coefficient ratio (ADC; the ADC of the suspected prostate cancer [PCa] focus on MRI divided by the ADC in a noncancerous reference area) with that of conventional ADC for detection of high-grade PCa (Gleason score [GS] ≥ 3 + 4) versus low-grade PCa (GS = 3 + 3) with whole-mount (WM) histopathologic analysis used as a reference. The cohort of this retrospective study included 218 men with 240 unilateral PCa lesions assessed by both 3-T multiparametric MRI and whole-mount histopathologic analysis. ROIs were placed on individual lesions verified by WM histopathologic analysis, to calculate the mean ADC (ADC) and lowest ADC within each lesion (ADC), and within non-tumor-containing regions of the same tumor zone but on the contralateral side (ADC), to calculate the background ADC. The ADC (the ADC divided by the ADC) was calculated. The performance of individual ADC and ADC values in discriminating PCa with a GS of 3 + 3 from PCa with a GS of 3 + 4 or greater was assessed using the AUC value. The ADC had a higher AUC value for discriminating PCa lesions with a GS of 3 + 3 from those with a GS of 3 + 4 or greater (the AUC value increased from 0.70 using the ADC and 0.67 using the ADC [the minimum ADC of the PCa lesion] to 0.80 for the ADC and 0.72 for the ADC [the ADC divided by the ADC]; = 0.043). When stratified by PCa zonal location, the ADC had significantly more robust accuracy in the transition zone (the AUC value increased from 0.63 for ADC to 0.87 for ADC; = 0.019) compared with the peripheral zone (the AUC value increased from 0.74 for ADC to 0.78 for ADC; = 0.44). When analyzed on the basis of endorectal coil use, the ADC performed nonsignificantly better in both the endorectal coil and non-endorectal coil subcohorts, although it performed better in the former. As an intrapatient-normalized diagnostic tool, the ADC ratio provided the best AUC value for discrimination of low-grade from high-grade PCa on 3-T MRI.

Download full-text PDF

Source
http://dx.doi.org/10.2214/AJR.19.21365DOI Listing

Publication Analysis

Top Keywords

adc
31
adc adc
20
histopathologic analysis
12
auc increased
12
pca
9
apparent diffusion
8
diffusion coefficient
8
adc ratio
8
conventional adc
8
prostate cancer
8

Similar Publications

The chemokine CX3CL1 promotes intraperitoneal tumour growth despite enhanced T-cell recruitment in ovarian cancer.

Neoplasia

January 2025

Department of Gynecology and Obstetrics, Technical University of Munich, 81675 Munich, Germany; German Cancer Consortium (DKTK), partner site Munich, and German Cancer Research Center (DKFZ), Heidelberg, Germany. Electronic address:

T-cell recruiting chemokines are required for a successful immune intervention in ovarian cancer, and also for the efficacy of modern anticancer agents such as PARP inhibitors. The chemokine CX3CL1 recruits tumour-suppressive T-cells into solid tumours, but also mediates cell-cell adhesions, e.g.

View Article and Find Full Text PDF

Diffusion weighted imaging (DWI) is used for monitoring purposes for lower-grade glioma (LGG). While the apparent diffusion coefficient (ADC) is clinically used, various DWI models have been developed to better understand the micro-environment. However, the validity of these models and how they relate to each other is currently unknown.

View Article and Find Full Text PDF

Localized and Excimer Triplet Electronic States of Naphthalene Dimers: A Computational Study.

Molecules

January 2025

Istituto di Biostrutture e Bioimmagini-CNR (IBB-CNR), Via De Amicis 95, I-80145 Napoli, Italy.

We perform DFT calculations with different hybrid (ωB97X-D and M05-2X) and double hybrid (B2PLYP-D3 and ωB2PLYP) functionals to characterize the lowest energy triplet excited states of naphthalene monomer and dimers in different stacking arrangements and to simulate their absorption spectra. We show that both excimer and localized triplet minima exist. In the former, the spin density is delocalized over the two monomers, adopting a face-to-face arrangement with a short inter-molecular distance.

View Article and Find Full Text PDF

Immunotherapy in Recurrent Ovarian Cancer.

Biomedicines

January 2025

Gynecology Department, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital & Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen 518116, China.

Background/objectives: It remains challenging to treat recurrent ovarian cancer effectively as traditional interventions like chemotherapy and surgery have limited long-term efficacy, highlighting an urgent need for innovative approaches. Immunotherapy offers potential advantages in modulating the immune response against tumor cells and has emerged as a promising strategy in ovarian cancer management. This review discusses various immunotherapy modalities, including active and passive immune strategies, for recurrent ovarian cancer.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!